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The adsorption and release of Naproxen as a model drug was 
studied. The MCM-41 silica was chosen as a model adsorbent. The 
synthesis of mesoporous silica was performed by template method 
using cetyltrimethylammonium bromide CTAB as a pore directing 
agent. Synthesized MCM-41 material of high quality was used as a 
carrier for Naproxen. The loading procedure was performed at 
normal conditions and under vacuum. The release of drug was 
measured for differentially prepared samples. The results for MCM-41 
are compared to those measured for silica gel for column chro-
matography Si-100 containing substantially larger pores. The 
results are discussed taking into account the penetration of pore 
system by loading solution as well as in terms of the proportion of 
dimensions of Naproxen molecule and pore dimensions of MCM-41. 
Keywords: MCM-41 silica, Naproxen, adsorption, drug loading, 
release systems. 
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1.  INTRODUCTION 
 
Almost a quarter of a century has passed since a first drug delivery 
system DDS (Liposomal amphotericin B) was approved [1]. The most 
important functions of drug delivery systems are to control and make 
targeted the drug transport into cells, maintain drug concentration within 
the therapeutic level and reduce side effects [2]. Generally, DDS is built 
of 2 components: carrier and drug substance. The carrier matrix plays a 
crucial role in proper functioning of DDS. For the carrier is expected to 
be biocompatible, non-toxic, thermally and chemically stable. The drug 
release takes place from them in targeted and very often stimuli-
responsive manner [2–4]. Important is fact that the cost and time of 
creation a new DDS (about $20–50 million and 3–4 years, respectively) is 
much lower than to develop of a new drug (about $500 million and over 
10 years) [1]. It is obvious that scientists (especially material chemists 
and nanotechnologists) around the world are constantly working to create 
newer and better drug carriers and DDS. In the last decade one of the 
most popular matrices used as potential carriers in drug delivery system 
and in other biomedical applications are silica materials, especially 
mesoporous silica nanoparticles (MSNs) [5, 6]. Ordered mesoporous 
silica materials from the time of first synthesis in the early 90's are 
commonly used in adsorption, catalysis, separation and recently in 
biomedicine. MSNs like MCM-41, MCM-48, SBA-1, SBA-3, SBA-15, 
SBA-16 are tested to drugs delivery for different diseases e.g. 
inflammation, cancer, diabetes, neurological disorders and even as a 
carriers in gene therapy or biosensor in diagnosis. The reasons of their 
popularity are that these materials have a several advantages, such as 
unique ordered structure of high specific area and pore volume and 
consequently high sorption capacity. Moreover production of these 
materials is relatively simple, inexpensive and easy controllable. Finally, 
they are nontoxic and biocompatible which are the key requirements  
[5–7]. Therefore great number of papers is addressed to drug release from 
mesoporous silica nanoparticles. The great interest in regularly arranged 
silicas started in 2001 when Vallet-Regi and coworkers as a first reported 
the MCM-41 as Ibuprofen delivery system. They received a relatively 
high release percent of drug up to about 70 and 91  after 24 h and 72 h 
respectively. Since these investigations MCM-41 silica material and its 
variety modifications is the most frequently used as carriers for many 
types of medicaments i.e. Ibuprofen, Aspirin, Naproxen, Doxorubicin, 
MCM-41 silica as a host material for controlled drug delivery systems 47
Captopril, Erythromycin [6, 8–10]. Vallet-Regi et.al/Zeng et.al./Hala-
mova et.al. studied the amine modified MCM-41 materials respectively as 
Ibuprofen, Aspirin and Naproxen carrier. They observed the decrease of 
drug release, because the ionic interactions between amine groups and 
carboxylic groups of drugs, and increase the total amount of drug loaded 
into silica material, because of better adsorption of anionic drugs on 
modified MCM-41 material of cationic character [11, 12]. Horcjada et.al 
studied also the modified MCM-41 silica with different organosilanes 
(Ph, But, Cl-Prop, SH-Prop, CN-Prop) as Ibuprofen host material. In this 
case they had drawn similar conclusions. Ibuprofen was better adsorbed 
on polar group of modified MCM-41 material than on modified of non-
polar character. The drug release from material modified with non-polar 
groups was higher than from modified matrix with polar species [13]. 
Horcjada et.al also investigated the influence of pore size MCM-41 on 
Ibuprofen rate delivery. They synthesized MCM-41 materials with 
different pore size (with diameter range from 2.5 nm to 3.6 nm), by using 
various types of surfactants containing different number of carbons in tail 
(from C8 to C16). Delivery rate of ibuprofen was increasing with 
increasing pore size of silica matrix [14]. Le-Le Yu Hong Bi developed 
the hybrid nanospheres MCM-41/iron oxide as a magnetic controlled 
DDS, to the target delivery of doxorubicin hydrochloride, which is a 
common anticancer drug. Amount of released drug in magnetic field was 
about 20% higher (at pH = 5.5) than in sample without field. They also 
examined the cytotoxicity of MSNs on human cells (HepG2) and they 
proved that the mesoporous silica nanoparticles are characterized by low 
cytotoxicity and high biocompatibility [15]. Summing up, one can say 
that silica materials, especially MCM-41 and its modifications, are still 
one of the most popular potential host materials for therapeutic 
substances.   
Below we presented information about mesoporous silica MCM-41 
and adsorption process of drug on these materials. Naproxen was used as 
a model drug in our experiments. In experimental part we presented 
results obtained for silica materials used as host material for Naproxen 
delivery system.  
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2. MCM-41 SILICA MATERIALS 
 
2.1. Synthesis and features 
The MCM-41 material was synthesised by a liquid crystal templating 
(LCT) in 1992 by scientists from Mobil Oil Company [16]. Their 
procedure of production consists in the formation of micelles in aqueous 
solution of surfactant, followed by the hydrolysis and polycondensation 
of a silica source in alkaline solution and finally the removal of 
surfactants from the pores of the material by calcination in 500-550°C 
Fig. 1 [5, 17–20].  
 
Fig. 1. Scheme of synthesis the MCM-41 silica material. 
 
It is worth to pay attention to these silica due to their extremely high 
pore volume (~1-2 cm3/g) and consequently high adsorption capacity 
(high specific surface area ~1000 m2/g). Very useful feature is also the 
regularity of pore shape and uniformity of pore dimension. MCM-41 
materials posses hexagonally arranged pores with long-range structural 
regularity. Both ends of cylindrical pores are likely open. As synthetized 
very fine particles of this silica can be easily formed in tablets or pellets 
without the deformation or collapse at pore system due to their 
mechanical stability, which is not insignificant in creating new drug 
delivery systems [1, 5, 18, 19]. 
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2.2. Drug adsorption process 
Most commonly used method for drug loading is impregnation in 
drug solution. Usually drugs are not satisfactory soluble in water. Thus, 
impregnations are performed using typical solvents like ethanol, 
acetonitrile or hydrocarbons like n-hexane. To facilitate the increase of 
drug loading from the aqueous solutions, salt of drugs are used, which are 
easy soluble in water and polar solvents. For solids equilibrated with 
binary solution containing drug both components are present in the 
surface phase. For solids where pores are large enough and their 
dimensions are within mesopore range there existing possibility to form 
the multilayer of preferentially adsorbed component (drug) on the pore 
walls. In the case of MCM-41 the formation of multilayer is strongly 
restricted from steric reasons. Thus adsorption of drug and competition 
for silica surface become most important factor regulating the amount of 
drug deposited. The aim of the experimental efforts is to optimize 
satisfactory the adsorption process and to cause that adsorption of drug is 
strongly preferential. The adsorption of relatively large drug molecules is 
determined by several factors, which may be summarized as follows: 
1. The interactions of adsorbate/drug molecule with the silica surface. 
Walls of pores in MCM-41 consist an amorphous silica gel. Thus the 
surface of silica gel condensed around micelles of pore directing agent 
contains the surface silanol groups of acidic character. The presence 
of hydroxyl groups enhanced the interactions with polar compounds 
like water, alcohols, amines and other chemical species containing 
heteroatoms. However, the hydroxyls originated from silica acid 
easily condense. Condensation starts, according to the literature data 
above 200°C and is followed by formation at siloxane bridges which 
are of hydrophobic character. The conventional procedure of the 
MCM-41 synthesis is completed after calcination at 550°C for 8 h 
causing the degradation and removal of surfactant molecules. 
Calcination causes the increase of hydrophobic properties of silica 
surface. On the other hand the water treatment at acidic conditions 
makes possible partial rehydroxylation process. As a result the MCM-
41silica adsorbs quite noticeably water. The state of silica surface in 
pore interior is a crucial parameter for adsorption of drug molecules. 
Thus, the state of silica should be carefully controlled [18, 21]. 
2. The adsorption of drug molecules is strongly determined by pore 
dimensions. In MCM-41 silica the pore diameter is dependent on the 
chain length of surfactant molecules being the basic element of pore 
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micellar matrix. The longer is the hydrocarbon chain in surfactant 
molecule the larger diameter of pores is created in MCM-41 silica. 
Additionally, the increase of pore dimensions may be realized by 
swelling of micelle template in auxiliary organics. Typically used 
surfactants in MCM-41 synthesis contain 12, 14, 16 or 18 carbon 
atoms in hydrophobic tail. All these pore directing agents lead to very 
narrow pores which may be ascribed to the lower limit of mesopores. 
If the pore diameters are too small during adsorption from gas and 
liquid phase the sieve effect may be expected. For example for 
standard drug molecule of ibuprofen the size of one molecule is as 
follows: 1 nm length and 0.6 nm width. The mix surfactants with 8 
and 10 (85% : 15%) carbon atoms as leads to the MCM-41 material 
with hexagonally arranged pores of 2.5 nm pore diameter. Thus, one 
can say that the adsorption of ibuprofen in pores of this material is 
more difficult from geometrical reasons than in the MCM-41 material 
with 3.6 nm pore diameter synthesised from C16 surfactant [9, 14]. 
One can assume that MCM-41 silica prepared with higher member of 
homologous series of the same type of surfactant will be adsorbed 
with same restriction due to the small ratio of the dimension of pores 
and cross-section of drug molecules. 
3. Further complication of embedding of drug molecules in pore interior 
of MCM-41 silica follow by the competitive adsorption of drug 
molecules and solvent molecules for silica surface. Typically, as for 
all processes of adsorption from the liquid mixtures both components 
of the bulk solution being over the solid, are present in the surface 
phase. This effect diminishes substantially the adsorption of 
preferentially adsorbed component. The competition being the 
characteristic phenomenon in adsorption from solutions, play an 
important role during impregnation of porous solid with drug solution. 
Thus, it is very important to match appropriately the solvent to drug 
character. Solvent should be minimally active for silica surface and 
easy removable at lower temperatures [21]. 
4. Not without consequence is the shape of pores in solid carrier of the 
drug. The shape of pores influences mainly the accessibility of pore 
interior by drug molecules, as well as the diffusion into and out of 
pores. Pores with constricts or partially closed may be only partially 
filled with drug molecules. In this case a great part of pores may 
remain empty and inaccessible for larger molecules. Additionally, 
when the geometrical restrictions are comparable with the dimensions 
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of drug molecules, their presence may be the reason of irreversibility 
of adsorption. In this case part of entrapped molecules can’t be 
desorbed even at higher temperatures or at presence of active 
components like those presented in body fluid or salt water solutions. 
The presence of the restrictions causes that diffusions deviate from the 
Fickian mechanism [21].  
5. Finally, all above mentioned factors related to solid carriers of organic 
molecules strongly depend on the temperature. The higher 
temperature diminishes the adsorption of preferentially adsorbed 
component due to heat motion of molecules or changes the 
competition of both components for the surface. This last effect is 
very sensitive on temperature especially for solids exhibiting high 
energetic heterogeneity of the surface. It is obvious, that in the case of 
silica material the energetic heterogeneity of surface species is high 
and is the result of presence of different types of silanols Q4, n <0-4>, 
as well as relatively high roughness of silica surface being the result 
of the irregular growth of silica skeleton during condensation process 
[18, 21]. 
On the other hand all listed features of porous silica materials offer a 
great possibility of the modelling of pores and silica surface character to 
fulfil the specific requirements of drug release systems.  
 
2.3. Modification of MCM-41 silica materials 
To facilitate more effective loading of drug molecules into MCM-41, 
the pore system of silica, the shape of pores and the chemical state of 
silica surface may be modified in different ways: modifying synthesis in 
the mother solution (changing temperature, pH or aging time or co-
condensation with other silanes) and by post-synthesis treatment of as-
synthesized silica: 
1. The modification of pore dimensions on the stage of synthesis may 
be realized by, as it was mentioned earlier, by change of the 
surfactant. This is a main method for tailoring of the pore diameter. 
However, also important is the modification of the surface character 
by treatment with different chemical species. In addition, to typically 
used in MCM-41 synthesis tertaethyl orthosilicate (TEOS) another 
silane containing in the molecule organic ligand which is bonded 
directly to silicon atom and doesn’t hydrolyse e.g. (C2H5O)3CH3~Si 
is commonly used as a method of chemical modification during sol-
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gel process. As a result we obtain silica surface with desired organic 
groups enhancing the interaction with specific drug molecule. Using 
appropriate silane it is possible to introduce on the internal pore wall 
surface appropriate active ligand. Very often the organic ligands like: 
-CH3, -NH3, -SH, -SO3H are introduced. [9, 10, 18].  
2. Post synthesis modification include usually the chemical 
modification of calcined mesoporous silica by using silanizing agents 
e.g. 3-aminopropyltriethoxysilane (APTES) [9].   
Distribution of functional groups on MCM-41 surface varies 
depending on the method of modification. In the case of co-condensation 
modification the functional groups are more evenly distributed inside 
pores of mesoporous silica than in post-synthesis modification [10]. Both 
modification procedures in which organic ligands are used cause the 
change of pore diameter. In post-synthesis modification by APTES the 
MCM-41 pore diameter decreases from 2.5 nm to 1.7 nm, in contrast to 
co-condensation modification, where the pore diameter decreases only to 
2.2 nm [22].  If the bonded phase is dense the reduction of pore diameter 
may be substantial. The adsorption on chemically bonded silica surface 
depends on the density and thickness of the organic phase. On modified 
silica surface takes place between organic deposits or between long alkyl 
chains of modifier. In this last case the adsorption is especially sensitive 
on the temperature. 
Adsorption on silica surface depends mainly on surface silanols. 
Their number for fully hydroxylated silica is practically constant and 
equal to 7.8 µmol/m2 [23]. Thermal treatment diminishes the concentration 
of silanols due to their condensation into siloxane bridges. Thermal 
treatment practically does not change the dimensions of pores. 
Additionally, the silica surface may be modified without reduction of pore 
dimensions in following ways [24, 25]: 
− addition of metal ion like Al, Zr, during sol gel process and 
entrapment these ions in silica network, 
− co-condensation of silane being silica source with silane 
containing no hydrolysing ligand e.g. alkyl(trimethyl/ethyl) 
silane. 
The compatibility of interactions between silica surface and drug 
may be enhanced by suitable modification of capillary channels of silica. 
However, as it was mentioned earlier the introduction of large organic 
groups in MCM-41 causes the decrease of pore dimensions and 
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additionally worsening of pore shape regularity and ordering. For full 
understanding of the procedures related to the loading of organic 
molecules into pore system of MCM-41 one have to take into account the 
proportion of the dimensions of organic molecule and pore diameter 
being the result of the modification procedure. 
 
 
3.  NAPROXEN 
 
Naproxen (S)-6-Methoxy-α-methyl-2-naphtalenacetic acid (C14H14O3) 
[Fig. 2] is well-known member of non-steroidal anti-inflammatory drug 
(NSAID). Its activity consist in inhibition of enzymes cyclooxygenase 1 
and 2. Thanks its anti-inflammatory, analgesic and antipyretic properties 
this drug is widely used to reduction pain, fever, inflammation and 
stiffness, caused by conditions such as osteoarthritis, rheumatoid arthritis, 
gout and injury [26]. NSAIDs are the most commonly used drugs in the 
world. Unfortunately, they cause serious side effects especially from 
gastrointestinal tract. It is estimated that about 1100 people die every year 
from complications after taking NSAIDs [27]. Therefore still ongoing 
studies to improve forms of these drugs by creating a novel carriers or 
more advanced drug delivery systems (DDS).  
 
 
Fig. 2.  Structure of the Naproxen molecule (white balls – hydrogen atoms, grey 
 balls – carbon atoms, black balls – oxygen atoms). 
 
In the present paper we present the influence of two different drug 
loading methods on efficiency of adsorption and release of this 
medicament from MCM-41 matrix. Mesoporous MCM-41 silica material 
was used as a drug carrier. Naproxen was used as a model drug. Drug 
loading process into MCM-41 material was performed from the ethanol 
solution at different conditions. Release process was realized to the 
phosphate buffer pH = 7.4 at 37°C.  
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4.  EXPERIMENTAL 
 
4.1. Synthesis of MCM-41 
MCM-41 silica material was prepared according to the following 
procedure [28]: 2.4 g of C16TAB was dissolved in 120 cm3 of deionized 
water. After that 11 ml of NH4OH (25%) was added to the surfactant 
solution. The solution was stirred for 15 min then 10 g of tetraetoxysilane 
TEOS was added dropwise for 30 min. Reaction mixture was stirred for  
2 h to get white precipitate. Then the solid, white product was filtered, 
washed with deionized water and dried at 60°C. As synthesized material 
was calcined at 550°C for 8 h. Finally, a white pure silica product was 
obtained. 
 
4.2. Characterization of MCM-41 
4.2.1. Nitrogen adsorption 
Nitrogen adsorption isotherms was measured at –196°C using 
Micromeritics apparatus ASAP 2420 (USA 2012). Prior experiment the 
sample was outgassed at 200°C in a vacuum for 1h.  
 
4.2.2. X-ray diffraction 
Powder X-ray diffraction was used to characterize the regularity of 
pore and dimension of pores. The measurements were performed with 
PANalytical apparatus Empyrean (Netherlands 2012). 
 
4.2.3. SEM electron microscopy 
The morphology of the sample was observed using a FEI  
high-resolution scanning electron microscope Quanta 3D FEG working at 
30 kV.  
 
4.3. Drug loading and desorption 
4.3.1. Drug loading 
The model drug was loaded into silica matrix in the following two 
ways. In the first one Naproxen (NXA) was loaded into MCM-41 silica 
material by impregnation method. Silica matrix was wetted by ethanol 
solution of Naproxen (24 mg/cm3). The amount of solution was equal to 
pore volume and final sample was visually dry. Prepared sample was left 
for 1h at room temperature then was dried for 12h at 60°C. The dried 
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sample was named as I.MCM-41-NXA. The amount of absorbed NXA in 
the sample was sample 5% NXA (54 mg NXA/1g MCM-41). The amount 
of solution was equal to solution volume required for full filling of the 
pores. In the second way Naproxen was loaded into MCM-41 silica 
matrix by immersion with ethanol solution of Naproxen (16 mg/cm3) 
under vacuum for 0.5h, and then the mixture was left over night at normal 
conditions.The solution was added with excess and MCM-41 silica was 
equilibrated with the bulk solution present over the sample. Next the 
sample was dried for 12h at 60°C. The dried sample was named as 
II.MCM-41-NXA. The amount of absorbed NXA in the sample was 20% 
NXA (233mg NXA/1g MCM-41). One can expect that the vacuum 
conditions will improve the penetration of small pores of MCM-41by 
both solution components. Under vacuum the air present in pores is 
evacuated and after outgassing the inflow of solution into pore interior is 
facilitated. The aim of this paper was to test the efficiency of drug release 
depend on drug loading. 
 
4.3.2. Drug desorption 
The drugs desorption experiments were performed by adding 200mg 
of investigated sample to vessels containing 50 cm3 (I sample) or 100 cm3 
(II sample) buffer solution pH 7.4 (77.4 cm3 de 1 M Na2HPO4 + 22,6 cm3 
de 1 M NaH2PO4) placed in incubation shaker. The temperature was fixed 
to 37°C and a stirring rate of 250 rpm was applied. At predetermined time 
intervals 5 cm3 of release fluid were taken out for analysis of the drug 
concentration with UV-Vis spectrometer (Varian Carry 100 Bio) at 
a wavelength of 330 nm for NXA. Taken aliquot were replenished with 
fresh dissolution medium. The concentration of drugs in each sample was 
determined by comparison with a calibration curves based on the 
absorption maximum at 330 nm. 
 
5.  RESULTS AND DISCUSSION 
 
5.1. Nitrogen adsorption 
The desorption of Naproxen from mesoporous silica in release 
solution is determined mainly by the geometrical structure of the carrier. 
Thus, first of all the basic parameters characterizing pore structure of 
silica under study were estimated. The adsorption/desorption isotherms of 
nitrogen on MCM-41 sample at –196°C were used to estimate the 
numerical values of the parameters characterizing porosity of silica. In 
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Fig. 3 the adsorption/desorption isotherms for sample under study are 
shown. 
 
 
Fig. 3. Nitrogen adsorption (full points)/desorption (open points) isotherms at –196°C  
 of MCM-41 silica. 
As is seen in Fig. 3. the shape of isotherms is of type-IV, which is 
characteristic for mesoporous sorbents. The steep rise of isotherm at  
p/p0 = 0.4 reflects the condensation of adsorbate in pores dominating in 
the pore system. Almost perpendicular rise of adsorption indicates that 
pores are very uniform in size and are regularly arranged. The numerical 
values of parameters characterizing pore system: specific surface area 
SBET and total pore volume Vp were derived from adsorption data. SBET 
was calculated using Brunauer-Emmett-Teller method in p/p0 range from 
0.05 to 0.25. Total pore volume was calculated from single point 
adsorption at p/p0 = 0.985. Pore size distribution PSD was estimated using 
Barrett-Joyner-Halenda procedure from adsorption and desorption branch 
of isotherm within the condensation range i.e. for p/p0 above 0.4. In 
calculations of SBET the area of nitrogen molecule occupied in the surface 
phase was assumed as ωN2 = 0.162 nm2. Calculated parameters for MCM-41 
silica under study are as follows: SBET  = 1070 m2/g, Vp = 1.1 cm3/g, mean 
pore diameter D = 4Vp/SBET = 2 nm. Mean pore diameter calculated in the 
above given manner represent the so called hydraulic diameter 
corresponding to cylindrical pore model. For solid characterized by 
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symmetrical pore size distribution this pore diameter is equal to the pore 
diameter at the peak of pore size distribution. In our case pore diameter at 
the peak of pore size distribution (Fig. 4) is centered at 2.8 nm for the 
desorption branch of isotherm and 3.2 nm for the adsorption branch [29].  
 
 
Fig. 4.  The pore size distribution for MCM-41 silica calculated by BJH procedure 
  – dash  line - adsorption branch, solid line - desorption branch. 
 
5.2. X-ray diffraction 
For the same sample of MCM-41 silica was calculated the pore 
diameter from X-ray diffraction data XRD. 
Fig. 5 depicts the XRD pattern of investigated MCM-41. As it is seen 
in Fig. 5 the silica shows well defined three XRD peaks. First located at 
2θ = 2.2 nm and indexed as (100) is assigned to hexagonally arranged 
pore structure p6mm. Two remaining peaks are located above 2θ = 4 nm. 
The d(100) spacing calculated according to Bragg’s law for 2θ equal to 
3.96 nm is typical for MCM-41 silica prepared with CTAB as template. 
On the basis of obtained d(100) value we can calculate additional 
parameters characterizing pore structure of investigated material i.e. unit 
cell dimension: 
  = 	
√  (1) 
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and pore diameter [30]: 
 	 = 	  ∙∙
/
 (2) 
where: c – constant equal 1.213, Vp –  pore volume resulting from N2 
sorption, ρ – pore wall density equal to 2.2 g/cm3. 
 
 
Fig. 5. X-ray diffraction pattern of MCM-41 silica under study. 
 
Knowing both these values we can calculate the pore wall thickness:  
  = 	 −		  (3) 
The results of our calculations based on XRD data indicate that the 
diameter of the pore is equal to 3.9 nm, and the thickness of the wall of 
pore is equal to 0.7 nm. 
Comparing the adsorption data of nitrogen and the results of X-ray 
diffraction experiment (Table 1) one can observe that the values of pore 
diameter obtained by different techniques don’t coincide. The pore 
diameter derived from XRD data is higher as compared with pore 
diameter calculated from desorption experiment but is congenial to 
adsorption results. This discrepancy is observed for many materials and 
discussed elsewhere [31]. Both used techniques confirm only that 
investigated silica material exhibits highly regular structure and contains 
mesopores of uniform size.  It means, that desorption of Naproxen in the 
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liquid phase takes place similarly as in gaseous phase simultaneously 
from all pores and the desorption mechanism is for these pores the same.  
 
Table 1. Structural parameters obtained from the nitrogen adsorption/  
     desorption and XRD data for MCM-41 sample under study. 
Parameter Value 
SBET [m2/g] 1070 
Vp [cm3/g] 1.1 
D1 (4Vp/SBET) [nm] 2 
D2 (PSD-adsorption branch) [nm] 3.2 
D3 (PSD-desorption branch) [nm] 2.8 
D4 (Wd XRD) [nm] 3.9 
b [nm] 0.7 
* D1 – hydraulic parameter, D2,3 – pore diameter at the peak of PSD 
adsorption/desorption branch respectively, D4 – pore diameter from XRD data. 
 
5.3. SEM electron microscopy 
SEM experiment provides information on the morphology of 
MCM-41 particles. Two most representative pictures of MCM-41 silica 
after calcination are shown in Fig. 6.   
 
 
Fig. 6. Representative SEM images of MCM-41 silica material. 
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The SEM images shown in Fig. 6 indicate that the SiO2 particles are 
very fine and approximately spherically shaped. The diameter of the 
particles is rather similar and do not exceeds 500 nm. The silica particles 
form aggregates which contain a large number of similar in size spherical 
particles and small amount of those irregularly shaped. 
 
5.4. Drug desorption 
Fig. 7 shows the results of Naproxen release from both of MCM-41-
drug conjugates (triangles and squares plots). The differentiation of the 
shape of desorption curves for Naproxen indicates that the evacuation 
mechanism of drug from MCM-41 silica is different. It should be 
mentioned that the amount of Naproxen loaded in impregnation process 
in vacuum is 4 times higher than during loading without outgassing. The 
release of Naproxen from I.MCM-41 sample is very fast and during 
twenty minutes almost 90% of drug is released. It means that Naproxen is 
located mainly on the external surface of particles or around the openings 
of pores. It is possible that during wetting process into pore interior 
penetrate mainly alcohol and large part of Naproxen remains out of pores. 
Much higher amount of drug about 20 w/w% recalculated on 1 gram of 
pure silica in II.MCM-41 sample is released much longer. Taking into 
account that the volume of the release solution is larger in the case of 
second sample one can assume that the final drug concentration in the 
bulk solution of this sample is similar to that for lower loaded sample. 
Thus, the shape difference of the release curves is the result of different 
release mechanism. As in the case of I.MCM-41 sample the drug crystals 
are located rather on the external surface of silica particles. However, in 
II.MCM-41 the drug is entrapped in the interior of narrow pores. The 
diffusion from these pores is substantially restricted. Release profile from 
I.MCM-41-NXA sample is characterized with strong initial burst effect 
followed by a very slow drug release. Fast and complete release of drug 
in a short time is characteristic for non-porous or macroporous silica 
adsorbents. That type of drug release can be use when initially is required 
a high dose drug e.g. in pain or inflammations. The rapid release of 
Naproxen was being the result of its location at least in part out of pores. 
This maybe also caused by strong competition of drug and ethanol for 
internal surface in wetting process. Much lower loading of Naproxen in 
I.MCM-41-NXA suggests also that part of pore system was not accessible 
for solution components. Thus, at restricted availability, when alcohol is 
strongly preferentially adsorbed Naproxen remains out of the pore 
system. The release in this case is determined mainly by dissolution 
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process. Release profile from II.MCM-41-NXA sample follows first-
order kinetics and it is associated with dissolution and diffusion processes. 
The drug is released in a less rapid and more monotonic manner. The 
observed effect clearly indicate, that the release process is mainly 
determined by the porosity of the carrier. To verify of this hypothesis the 
release of Naproxen was measured for silica gel for column 
chromatography Lichrosorb Si-100 (from Merck, Darmstadt, Germany). 
This silica gel contains relatively large pores sized approximately 10 nm in 
diameter. For comparative purposes in Fig. 7 is presented the release curve 
for Naproxen from Si-100 silica gel (circles) loaded with 1.2% (13 mg 
NXA/g Si-100). As is seen the release of drug from Si-100-NXA was very 
fast and exhibits a characteristic burst effect (90 % drug was released 
within first 15 min). This type of profile is typical for macroporous silica 
adsorbents. The shape of release curve is similar to that for MCM-41 after 
simple impregnation. Thus, one can conclude that for continuous release 
within long period of time it is necessary to introduce of drug into pore 
interior of relatively narrow diameter. 
 
 
Fig. 7. Naproxen release curves from MCM-41(triangles – sample without 
  outgassed; squares – sample with outgassed) and SiO2-100 (circles) 
  silica material. 
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As it was mentioned above in the outgassed sample it is possible to load 
up to 20 w/w % of Naproxen which is strongly entrapped in internal pore 
system of MCM-41. However, part of drug originating from the excess 
volume of solution probably occupies the external surface of particles. It is 
worth to notice that introduced drug does not fill totally the free volume in 
pores, which exceeds 1 cm3 per gram. Due to restricted pore volume one 
can expect that Naproxen form is rather non-crystaline and the Naproxen 
clusters are distributed randomly along silica pores. It is also possible that 
Naproxen is incorporated into MCM-41 in the form of multi-molecular 
layer. Between drug particles or molecules still remain free volumes 
available for solvent molecules in desorption experiment. One can expect 
that density of packing of drug in pore interior is the factor regulating the 
release. Thus, interesting seems to be to compare the dimensions of 
Naproxen molecule in two dimensions, the cross-section and the length to 
pore dimension. The appropriate proportions are illustrated in Fig. 8. 
 
Fig. 8.  Structure and size of the Naproxen molecule: A – the length and, B – the  
 width. The reported values were found for the structure optimized at the 
 DFT/B3LYP level [32] with 6-31G* basis set [33]. 
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From the illustration presented in Fig. 8 and 9 one can conclude that 
the Naproxen molecule is relatively large if we relate its dimension to 
pore diameter of MCM-41 silica. The length of Naproxen molecule 
estimated from model calculations is ~ 1.17 nm and width is ~ 0.5 nm. 
However with consideration of dimension with Van der Waals spheres of 
extreme hydrogens atoms the size increases to ~ 1.41 nm in length and ~ 
0.74 nm in width respectively. So that, the loading of Naproxen into 
MCM-41 pores is strictly dependent on the arrangement of drug 
molecules in internal pore space. Any constrictions or geometrical defects 
may reduce the drug loading or its release to external media. 
 
Fig. 9. Schematic comparison of the size (width and length) of Naproxen 
  molecule to the diameter of MCM-41 pore (assumed as 3 nm). 
 
 
6.  CONCLUSIONS 
 
Mesoporous silica materials of MCM-41 type are attractive from the 
point of view of drug loading in drug delivery systems. High pore volume 
and specific surface area are the important factors in drug loading 
process. Pore volume can’t be totally filled with drug molecules in 
impregnation process and loading strongly depends on the interactions of 
drug with the mesoporous host and the rate of wettability by solution 
containing the drug. The wettability and the penetration of pores by 
wetting liquid are markedly improved in outgassed sample. Outgassing of 
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the system composed the porous solid and wetting liquid causes that 
Naproxen loading is many times larger than without outgassing. 
Moreover, the location of drug is dependent on the loading conditions. 
Wetting of mesoporous solid at normal pressure is incomplete and part of 
pores is inaccessible for solution. After outgassing under lower pressure 
the solution penetrates the silica pore system entirely. The amount of drug 
deposited in pores depends on equilibrium of adsorption process. In the 
case of highly porous solids containing pores of small dimensions very 
important is the relation of pore dimension to dimensions of adsorbed 
molecules. The dimensions of Naproxen molecules are comparable with 
MCM-41 pore diameter. Thus the competition of Naproxen and alcohol 
molecules for silica surface plays the main role in drug loading. In pore 
interior, over the adsorbed Naproxen molecules the presence of the bulk 
liquid is strongly limited. Maximal loading of MCM-41 under vacuum 
corresponds to 20 w/w % contamination of Naproxen. The release of 
Naproxen from this system takes a longer time than for wideporous silica 
nd takes place without burst effect.  
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